Antibacterial and Antibiofilm Activities of β-Lapachone by Modulating the Catalase Enzyme

Overview

Journal Antibiotics (Basel)

Specialty Pharmacology

Date 2023 Mar 29

PMID 36978443

Authors

Mushtaq Ahmad Mir

Somaya Ahmed Altuhami

Sukanta Mondal

Nasreena Bashir

Ayed A Dera

Mohammad A Alfhili

Affiliations

Soon will be listed here.

Abstract

Background: Bacterial infections constantly have a large impact on public health, because of increased rates of resistance and reduced frequency of development of novel antibiotics. The utility of conventional antibiotics for treating bacterial infections has become increasingly challenging. The aim of the study was to assess the antibacterial effect of β-Lapachone (β-Lap), a novel synthetic compound.

Methods: The antibacterial activity of the β-Lap compound was examined against laboratory strains by agar well diffusion method and broth dilution assay. Growth kinetics in presence of β-Lap on , , and (ATCC 27853) were assessed by microplate alamarBlue assay. Crystal violet blue assay was used for biofilm inhibition and biofilm eradication. catalase (KatA) complexed with β-Lap was modeled using molecular docking approach.

Results: β-Lap exhibited potent antimicrobial activity against laboratory strains of bacteria with MIC of 0.2 mM for and , and 0.04 mM for and ATCC 27853. The inhibition of catalase enzyme was found to be the cause for its antibacterial activity. Bioinformatics analysis suggests that β-Lap can inhibit KatA activity by interacting with catalase proximal active site and heme binding site. The activity of some commercial antibiotics was enhanced in association with β-Lap. In addition, β-Lap inhibited the biofilm formation and eradicated the already formed and ultra-mature biofilms of aforesaid bacterial strains.

Conclusion: These observations indicated that β-Lap could be a promising antibacterial agent for the treatment and prevention of infectious diseases.

Citing Articles

Antimycobacterial and Anticancer Properties of Leaf Extract.

Mir M, Memish L, Elbehairi S, Bashir N, Masoud F, Shati A Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065723 PMC: 11279575. DOI: 10.3390/ph17070872.

Design, synthesis, and unraveling the antibacterial and antibiofilm potential of 2-azidobenzothiazoles: insights from a comprehensive study.

Qadir T, Kanth S, Aasif M, Fadul A, Yatoo G, Jangid K Front Chem. 2023; 11:1264747.

PMID: 37744062 PMC: 10513370. DOI: 10.3389/fchem.2023.1264747.

References

Wu H, Moser C, Wang H, Hoiby N, Song Z . Strategies for combating bacterial biofilm infections. Int J Oral Sci. 2014; 7(1):1-7. PMC: 4817533. DOI: 10.1038/ijos.2014.65. View

Jones W, Chin Y, Kinghorn A . The role of pharmacognosy in modern medicine and pharmacy. Curr Drug Targets. 2006; 7(3):247-64. DOI: 10.2174/138945006776054915. View

Kim S, Chen J, Cheng T, Gindulyte A, He J, He S . PubChem 2023 update. Nucleic Acids Res. 2022; 51(D1):D1373-D1380. PMC: 9825602. DOI: 10.1093/nar/gkac956. View

Gong Q, Hu J, Wang P, Li X, Zhang X . A comprehensive review on β-lapachone: Mechanisms, structural modifications, and therapeutic potentials. Eur J Med Chem. 2020; 210:112962. DOI: 10.1016/j.ejmech.2020.112962. View

de Almeida E, Da Silva Filho A, Dos Santos E, Lopes C . Antiinflammatory action of lapachol. J Ethnopharmacol. 1990; 29(2):239-41. DOI: 10.1016/0378-8741(90)90061-w. View

Ieque A, Carvalho H, Baldin V, Santos N, Costacurta G, Sampiron E . Antituberculosis Activities of Lapachol and β-Lapachone in Combination with Other Drugs in Acidic pH. Microb Drug Resist. 2020; 27(7):924-932. DOI: 10.1089/mdr.2020.0164. View

Calixto J . The role of natural products in modern drug discovery. An Acad Bras Cienc. 2019; 91 Suppl 3:e20190105. DOI: 10.1590/0001-3765201920190105. View

Llor C, Bjerrum L . Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014; 5(6):229-41. PMC: 4232501. DOI: 10.1177/2042098614554919. View

Salentin S, Schreiber S, Haupt V, Adasme M, Schroeder M . PLIP: fully automated protein-ligand interaction profiler. Nucleic Acids Res. 2015; 43(W1):W443-7. PMC: 4489249. DOI: 10.1093/nar/gkv315. View

10.

Fernandes A, Santos V, Araujo C, de Oliveira H, da Costa M . Anti-biofilm Effect of β-Lapachone and Lapachol Oxime Against Isolates of Staphylococcus aureus. Curr Microbiol. 2019; 77(2):204-209. DOI: 10.1007/s00284-019-01818-1. View

11.

Costa D, Pereira Rangel L, Martins-Dinis M, Diniz da Silva Ferretti G, Ferreira V, Silva J . Anticancer Potential of Resveratrol, β-Lapachone and Their Analogues. Molecules. 2020; 25(4). PMC: 7070981. DOI: 10.3390/molecules25040893. View

12.

Hengzhuang W, Wu H, Ciofu O, Song Z, Hoiby N . Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother. 2011; 55(9):4469-74. PMC: 3165294. DOI: 10.1128/AAC.00126-11. View

13.

Stewart P . Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol. 2002; 292(2):107-13. DOI: 10.1078/1438-4221-00196. View

14.

Pereira E, Machado T, Correa Ramos Leal I, Jesus D, Damaso C, Pinto A . Tabebuia avellanedae naphthoquinones: activity against methicillin-resistant staphylococcal strains, cytotoxic activity and in vivo dermal irritability analysis. Ann Clin Microbiol Antimicrob. 2006; 5:5. PMC: 1435768. DOI: 10.1186/1476-0711-5-5. View

15.

Salas C, Tapia R, Ciudad K, Armstrong V, Orellana M, Kemmerling U . Trypanosoma cruzi: activities of lapachol and alpha- and beta-lapachone derivatives against epimastigote and trypomastigote forms. Bioorg Med Chem. 2007; 16(2):668-74. DOI: 10.1016/j.bmc.2007.10.038. View

16.

Cavalcanti I, Pontes-Neto J, Kocerginsky P, Bezerra-Neto A, Lima J, Lira-Nogueira M . Antimicrobial activity of β-lapachone encapsulated into liposomes against meticillin-resistant Staphylococcus aureus and Cryptococcus neoformans clinical strains. J Glob Antimicrob Resist. 2016; 3(2):103-108. DOI: 10.1016/j.jgar.2015.03.007. View

17.

Rodrigues T, Reker D, Schneider P, Schneider G . Counting on natural products for drug design. Nat Chem. 2016; 8(6):531-41. DOI: 10.1038/nchem.2479. View

18.

CRUZ F, Docampo R, Boveris A . Generation of superoxide anions and hydrogen peroxide from beta-lapachone in bacteria. Antimicrob Agents Chemother. 1978; 14(4):630-3. PMC: 352520. DOI: 10.1128/AAC.14.4.630. View

19.

Magiorakos A, Srinivasan A, Carey R, Carmeli Y, Falagas M, Giske C . Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2011; 18(3):268-81. DOI: 10.1111/j.1469-0691.2011.03570.x. View

20.

Sigrist C, de Castro E, Cerutti L, Cuche B, Hulo N, Bridge A . New and continuing developments at PROSITE. Nucleic Acids Res. 2012; 41(Database issue):D344-7. PMC: 3531220. DOI: 10.1093/nar/gks1067. View